Torrent Pharmaceuticals Ltd - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificate04-08-2021
04-08-2021
Hold Torrent Pharmaceuticals: target of Rs 3250: ICICI Direct
ICICI Direct recommended hold rating on Torrent Pharmaceuticals with a target price of Rs 3250 in its research report dated July 28, 2021.02-08-2021
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
Intimation under Regulation 30 of SEBI (Listing Obligation and Disclosures Requirements) Regulations, 2015, ("Listing Regulations")31-07-2021
Torrent Pharmaceuticals Ltd - 500420 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Torrent Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here29-07-2021
Buy Torrent Pharmaceuticals: target of Rs 3400: Sharekhan
Sharekhan is bullish on Torrent Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 3400 in its research report dated July 27, 2021.29-07-2021
Torrent Pharmaceuticals Ltd - 500420 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Declaration of Voting results of 48th AGM28-07-2021
Torrent Pharma share price rises led by India revenue growth in Q1; brokerages remain mixed
India revenues that constitutes more than half of Torrent Pharma revenues grew at 18 percent YoY to Rs 1,093 crore in Q1FY22, while US revenues dropped 29 percent to Rs 266 crore.28-07-2021
Earnings Call for Q1FY22 of Torrent Pharmaceuticals
Conference Call with Torrent Pharmaceuticals Management and Analysts on Q1FY22 Performance and Outlook. Listen to the full earnings transcript.27-07-2021
TORRENT PHARMACEUTICALS LTD. - 500420 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of 48th Annual General Meeting of the Company held on 27th July, 202127-07-2021
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Investor Presentation
The presentation on unaudited Consolidated Financial Results for the quarter ended 30th June, 2021 to be made to analysts is enclosed for your records.27-07-2021